# The Medicines (Products for Human Use — Fees) Regulations 1995, Regulation 5: Inspections in connection with multiple applications for authorizations or licences


Where an inspection mentioned in regulation 4(b) is made at a site which has been named as a possible site for manufacture or assembly of a medicinal product, or for the preparation of a substance which is to be used in the manufacture of an immunological product or a blood product, by more than one applicant for—
(a) a marketing authorization and that site is located outside the United Kingdom; or
(b) a manufacturer’s licence and that site is located in the United Kingdom,
the fee in respect of that inspection shall be payable in equal proportions by each of those applicants.

---
Source: https://www.legislation.gov.uk/uksi/1995/1116/regulation/5 (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-1995/regulation-5
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.